Product Information
ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ is a brand product labeled by Novo Nordisk, priced at $493.8960 per ML under NDC 00169191201. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Mar 22, 2021.
Strength
.6 mg/.6mL
Manufacturer
Novo NordiskNDC
00169191201
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/21/2026
Active Ingredients
DASIGLUCAGONApproval Type
New Drug (NDA)
FDA Application
NDA214231FDA Approved
3/22/2021
On Market Since
6/26/2023
Pharmacological Classes
Price Statistics
The NADAC for ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $493.8960 per ML |
|---|---|
| All-time high | $496.1636 (Jun 12, 2024) |
| All-time low | $493.8960 (Jan 21, 2026) |
| 52-week high | $494.5043 |
| 52-week low | $493.8960 |
| Median price | $494.5043 |
| Average price | $494.7116 |
| Largest weekly change | -0.4% (Jun 18, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novo Nordisk manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dasiglucagon market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihypoglycemic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ, manufactured by Novo Nordisk, is $493.8960 per ML (NDC 00169191201), effective Sep 30, 2026.
How has the price of ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ?
Since Apr 17, 2024, the NADAC for ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ has ranged from a low of $493.8960 (Jan 21, 2026) to a high of $496.1636 (Jun 12, 2024), with a median of $494.5043 per ML.
Are there cheaper alternatives to ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ, is $492.8315 per ML — about 0% below ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ.
Who manufactures ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ?
ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ (NDC 00169191201) is labeled by Novo Nordisk, and CMS classifies it as a brand product.